Skip to main content

Table 1 The pretreatment clinical characteristics of the subjects in the WMCGs and the 0.1% SH groups

From: Short-term effect of a developed warming moist chamber goggle for video display terminal-associated dry eye

 

WMCG group (N = 22)

0.1% SH group (N = 18)

 

Median (25%,75%)/

Median (25%,75%)/

P

Mean ± SD

Mean ± SD

Age (Year)

26.5 (25, 28.25)

26 (25, 27.25)

0.510

Gender (M:F)

8:14

6:12

0.968

VDT (h)

9.41 ± 1.87

9.79 ± 2.01

0.570

FBUT (s)

3.49 ± 0.97

3.52 ± 1.22

0.665

ABUT (s)

4.86 ± 1.34

4.92 ± 1.69

0.936

CFS

1 (0,3.25)

0 (0,2)

0.244

SIt (mm)

16.49 ± 10.98

15.63 ± 11.69

0.824

IOP (mmHg)

14.51 ± 2.38

15.00 ± 2.18

0.434

OSDI

37.49 ± 15.24

36.93 ± 16.69

0.918

  1. WMCGs warming moist chamber goggles, SH sodium hyaluronate, VDT video display terminals, FBUT first break-up time, ABUT average break-up time, CFS corneal fluorescein staining, SIt Shirmer I test, IOP intraocular pressure, OSDI ocular surface disease index